AzurRx BioPharma announced today that it has reached the sixth patient enrollment point in the ongoing 12-15 patient open-label Phase IIa trial of MS1819.
AzurRx BioPharma (NASDAQ:AZRX) announced today that it has reached the sixth patient enrollment point in the ongoing 12-15 patient open-label Phase IIa trial of MS1819.
As quoted in the press release:
AzurRx expects to report data from the first six patients in this study in September 2017.
While enrollment in the Phase IIa trial has been slower than anticipated, in order to further support enrollment in both this study and other planned future trials, AzurRx has added an additional clinical site in Australia.
“We are pleased to reach this point in enrollment of this important clinical trial,” said Thijs Spoor, CEO of AzurRx BioPharma. The additional clinical site in Australia is expected to drive enrollment in both this study and other future planned clinical trials. Following the positive interim data we reported in the second quarter on the first three patients in the Phase IIa study, we look forward to the availability of additional results from the first six patients in September.”
Click here to read the full press release.
Source: globenewswire.com
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1823.40 | -3.86 | |
Silver | 21.58 | -0.03 | |
Copper | 4.23 | +0.04 | |
Palladium | 1997.00 | -13.00 | |
Platinum | 946.00 | +1.00 | |
Oil | 113.82 | -0.38 | |
Heating Oil | 3.77 | 0.00 | |
Natural Gas | 8.04 | +0.09 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.